Colloidal semiconductor magic-size clusters (MSCs), a crucial link between molecular and bulk materials, have attracted attention in the past three decades. However, the identification of their nonbandgap electronic transitions via optical absorption has been challenging due to the possible presence of other-bandgap ensembles in synthetic batches. For CdSe MSC-415, referred to as the optical absorption (1S(e)-1S(h)) in nanometers of wavelength, we report our exploration on the origin of two commonly documented absorption peaks at 381 and 351 nm. We show that the evolution of the two peaks does not synchronize with that of the ∼415 nm peak and seems to be respectively related to the disappearance of MSC-391 and MSC-361. Accordingly, these two peaks detected are probably not due to higher order electronic transitions in MSC-415. The present study shows the necessity of re-evaluating previous experimental results and of developing advanced theoretical models to better understand the quantized energy levels of MSCs.
Little is known about the molecular pathway to monomers of semiconductor nanocrystals. Here we report a general reaction pathway, which is based on hydrogen-mediated ligand loss for the precursor conversion to ‘monomers' at low temperature before nucleation. We apply 31P nuclear magnetic resonance spectroscopy to monitor the key phosphorous-containing products that evolve from MXn+E=PPh2H+HY mixtures, where MXn, E=PPh2H, and HY are metal precursors, chalcogenide precursors, and additives, respectively. Surprisingly, the phosphorous-containing products detected can be categorized into two groups, Ph2P–Y and Ph2P(E)–Y. On the basis of our experimental and theoretical results, we propose two competing pathways to the formation of M2En monomers, each of which is accompanied by one of the two products. Our study unravels the pathway of precursor evolution into M2En monomers, the stoichiometry of which directly correlates with the atomic composition of the final compound nanocrystals.
/npsi/ctrl?lang=en http://nparc.cisti-icist.nrc-cnrc.gc.ca/npsi/ctrl?lang=fr READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE USING THIS WEBSITE.http://nparc.cisti-icist.nrc-cnrc.gc.ca/npsi/jsp/nparc_cp.jsp?lang=en Vous avez des questions? Nous pouvons vous aider. Pour communiquer directement avec un auteur, consultez la première page de la revue dans laquelle son article a été publié afin de trouver ses coordonnées. Si vous n'arrivez pas à les repérer, communiquez avec nous à PublicationsArchive-ArchivesPublications@nrc-cnrc.gc.ca.
Primary alkyl amines (RNH2) have been empirically used to engineer various colloidal semiconductor nanocrystals (NCs). Here, we present a general mechanism in which the amine acts as a hydrogen/proton donor in the precursor conversion to nanocrystals at low temperature, which was assisted by the presence of a secondary phosphine. Our findings introduce the strategy of using a secondary phosphine together with a primary amine as new routes to prepare high-quality NCs at low reaction temperatures but with high particle yields and reproducibility and thus, potentially, low production costs.
Primary alkyl amines (RNH 2 ) have been empirically used to engineer various colloidal semiconductor nanocrystals (NCs). Here, we present a general mechanism in which the amine acts as a hydrogen/proton donor in the precursor conversion to nanocrystals at low temperature, which was assisted by the presence of a secondary phosphine. Our findings introduce the strategy of using a secondary phosphine together with a primary amine as new routes to prepare highquality NCs at low reaction temperatures but with high particle yields and reproducibility and thus, potentially, low production costs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.